🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if SU011248 works and if it is saf...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2008-04
Trial ID
NCT00578526
AMB-051-07 is an open-label, adaptive, dose-ranging study with long-term ex...
Status
Completed
Location
AmMax Bio, Clinical Site
Start Date
2023-01-26
Trial ID
NCT05349643
Treatments Being Tested
This Phase I/IIa clinical study is testing an experimental treatment called...
Status
Recruiting
Location
Hospital Clínic de Barcelona
Start Date
2026-02-04
Trial ID
NCT07471789
Treatments Being Tested
One of the possible options for the treatment of MS at present is a high-do...
Status
Recruiting
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2020-10-01
Trial ID
NCT05832515
Treatments Being Tested
The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Status
Terminated
Location
Baylor College of Medicine - Methodist Hospital
Start Date
2007-05
Trial ID
NCT00522249
Treatments Being Tested
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This phase Ib/II trial studies the side effects of IRX-2, cyclophosphamide,...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2019-04-19
Trial ID
NCT03918499
Treatments Being Tested
At present, all commercially available corneal organ culture media contain ...
Status
Completed
Location
CHU Besançon
Start Date
2012-01
Trial ID
NCT01694914
Treatments Being Tested